Role of chronic inflammation in cancers of the gastrointestinal system and the liver: where we are now

Cancer Lett. 2014 Apr 10;345(2):150-2. doi: 10.1016/j.canlet.2013.10.013. Epub 2013 Nov 15.

Authors

Liang Qiao¹, Xun Li²

Affiliations

¹ Storr Liver Unit, Westmead Millennium Institute, the University of Sydney and Westmead Hospital, Westmead, NSW 2145, Australia. Electronic address: liang.qiao@sydney.edu.au.
² Hepatopancreatobiliary Surgery Institute of Gansu Province, Department of Surgery II, the First Hospital of Lanzhou University, Clinical Medical College Cancer Center of Lanzhou University, Lanzhou 730000, Gansu Province, China. Electronic address: lxdr21@sohu.com.

PMID: 24246847
DOI: 10.1016/j.canlet.2013.10.013

No abstract available

Publication types

Introductory Journal Article

MeSH terms

Animals
Anti-Inflammatory Agents / therapeutic use
Antineoplastic Agents / therapeutic use
Cell Transformation, Neoplastic / immunology
Cell Transformation, Neoplastic / metabolism
Chronic Disease
Gastrointestinal Neoplasms / drug therapy
Gastrointestinal Neoplasms / etiology*
Gastrointestinal Neoplasms / immunology
Gastrointestinal Neoplasms / metabolism
Humans
Inflammation / complications*
Inflammation / drug therapy
Inflammation / immunology
Inflammation / metabolism
Inflammation Mediators / metabolism
Liver Neoplasms / drug therapy
Liver Neoplasms / etiology*
Liver Neoplasms / immunology
Liver Neoplasms / metabolism
Prognosis
Risk Factors
Signal Transduction

Substances

Anti-Inflammatory Agents
Antineoplastic Agents
Inflammation Mediators